| GC14446-200mg |
|
1097917-15-1 |
|
0 |
C29H40N8O3S |
|
|
|
| GC14446-50mg |
|
1097917-15-1 |
|
0 |
C29H40N8O3S |
|
|
|
| GC14446-10mg |
|
1097917-15-1 |
|
0 |
C29H40N8O3S |
|
|
|
| GC14446-5mg |
|
1097917-15-1 |
|
0 |
C29H40N8O3S |
|
|
|
| GC14445-500mg |
|
133240-06-9 |
2-Ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridine
|
0 |
C10H13N3 |
|
|
|
| GC14445-250mg |
|
133240-06-9 |
2-Ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridine
|
0 |
C10H13N3 |
|
|
|
| GC14445-100mg |
|
133240-06-9 |
2-Ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridine
|
0 |
C10H13N3 |
|
|
|
| GC14443-20 μl (10 mM) |
|
— |
Granzyme B Inhibitor Z-AAD-CH2Cl
|
0 |
C20H26ClN3O7 |
|
|
|
| GC14442-50mg |
|
302799-86-6 |
|
0 |
C22H23N3O |
|
|
|
| GC14442-10mg |
|
302799-86-6 |
|
0 |
C22H23N3O |
|
|
|
| GC14441-10mM (in 1mL DMSO) |
|
459147-39-8 |
|
0 |
C21H20N2OS3 |
|
|
|
| GC14441-25mg |
|
459147-39-8 |
|
0 |
C21H20N2OS3 |
|
|
|
| GC14441-5mg |
|
459147-39-8 |
|
0 |
C21H20N2OS3 |
|
|
|
| GC14440-250mg |
|
50-90-8 |
|
0 |
C9H11ClN2O5 |
|
|
|
| GC14440-100mg |
|
50-90-8 |
|
0 |
C9H11ClN2O5 |
|
|
|
| GC14440-50mg |
|
50-90-8 |
|
0 |
C9H11ClN2O5 |
|
|
|
| GC14439-10mM (in 1mL DMSO) |
|
1477949-42-0 |
Santacruzamate A (CAY10683)
|
0 |
C15H22N2O3 |
|
|
|
| GC14439-50mg |
|
1477949-42-0 |
Santacruzamate A (CAY10683)
|
0 |
C15H22N2O3 |
|
|
|
| GC14439-10mg |
|
1477949-42-0 |
Santacruzamate A (CAY10683)
|
0 |
C15H22N2O3 |
|
|
|
| GC14438-50mg |
|
40828-46-4 |
|
0 |
C14H12O3S |
|
|
|
